keyword
MENU ▼
Read by QxMD icon Read
search

Colon Treatment Resistance Stroma

keyword
https://www.readbyqxmd.com/read/29121995/round-cell-sarcoma-of-the-colon-with-cic-rearrangement
#1
H Maghrebi, R Batti, A Zehani, N Chrait, H Rais, A Makni, A Haddad, M Ayadi, A Daghfous, M Jrad, N Kchir, Z Bensafta, A Mezlini
BACKGROUND: The CIC-rearranged sarcoma is a very rare highly aggressive malignant soft tissue group of tumors. It has recently been described as highly aggressive soft tissue tumors of children and young adults sharing similar morphological features with the Ewing sarcoma. The digestive localization is exceptional. CASE PRESENTATION: A 14-year-old male presented with a history of abdominal pain for 1 year, which increased in intensity over the last 2 months. Imaging findings showed a large heterogeneous mesenteric mass on the left flank of the abdomen...
November 9, 2017: BMC Research Notes
https://www.readbyqxmd.com/read/26556874/periostin-expression-in-intra-tumoral-stromal-cells-is-prognostic-and-predictive-for-colorectal-carcinoma-via-creating-a-cancer-supportive-niche
#2
MULTICENTER STUDY
Xiaowen Xu, Wenjun Chang, Jie Yuan, Xue Han, Xiaojie Tan, Yibo Ding, Yanxin Luo, Hui Cai, Yan Liu, Xianhua Gao, Qizhi Liu, Yongwei Yu, Yan Du, Hao Wang, Liye Ma, Jianping Wang, Kun Chen, Yanqing Ding, Chuangang Fu, Guangwen Cao
Periostin (POSTN) expression in cancer cells and circulation has been related to poor prognosis of colorectal carcinoma (CRC). However, the role of POSTN expressed in intra-tumoral stroma on CRC progression remains largely unknown. This study enrolled 1098 CRC patients who received surgical treatment in Shanghai and Guangzhou, Mainland China. In Shanghai cohort, immunohistochemistry score of stromal POSTN expression increased consecutively from adjacent mucosa, primary CRC tissues, to metastatic CRC tissues (P < 0...
January 5, 2016: Oncotarget
https://www.readbyqxmd.com/read/26392321/transforming-growth-factor-%C3%AE-signaling-induced-during-prostate-cancer-cell-death-and-neuroendocrine-differentiation-is-mediated-by-bone-marrow-stromal-cells
#3
Fayth L Miles, Senem Kurtoglu, Chris Ahmer, Mehrnoosh Soori, John S Favate, Robert A Sikes
INTRODUCTION: Prostate cancer that has metastasized to bone undergoes critical interactions with bone marrow stromal cells (BMSCs), ultimately promoting tumor survival. Previous studies have shown that BMSCs secrete factors that promote prostate cancer apoptosis or neuroendocrine differentiation. Because of the significance of transforming growth factor-β (TGF-β) family cytokines in cytostasis and bone metastasis, the role of TGF-β signaling in the context of prostate cancer-BMSC interactions was investigated...
November 2015: Prostate
https://www.readbyqxmd.com/read/24661671/tumor-radiation-therapy-creates-therapeutic-vaccine-responses-to-the-colorectal-cancer-antigen-gucy2c
#4
Matthew Witek, Erik S Blomain, Michael S Magee, Bo Xiang, Scott A Waldman, Adam E Snook
PURPOSE: Radiation therapy (RT) is thought to produce clinical responses in cancer patients, not only through direct toxicity to cancer cells and supporting tumor stroma cells, but also through activation of immunologic effectors. More recently, RT has potentiated the local and systemic effects of cancer immunotherapy (IT). However, combination regimens that maximize immunologic and clinical efficacy remain undefined. METHODS AND MATERIALS: We evaluated the impact of local RT on adenoviral-mediated vaccination against the colorectal cancer antigen GUCY2C (Ad5-GUCY2C) in a murine subcutaneous tumor model using mouse CT26 colon cancer cells (CT26-GUCY2C)...
April 1, 2014: International Journal of Radiation Oncology, Biology, Physics
https://www.readbyqxmd.com/read/23544165/cxcr4-expression-and-treatment-with-sdf-1%C3%AE-or-plerixafor-modulate-proliferation-and-chemosensitivity-of-colon-cancer-cells
#5
Doreen Heckmann, Patrick Maier, Stephanie Laufs, Frederik Wenz, W Jens Zeller, Stefan Fruehauf, Heike Allgayer
BACKGROUND: Signaling through stromal cell-derived factor-1α (SDF-1α), strongly secreted by bone marrow stromal cells and the CXC chemokine receptor 4 (CXCR4) exposed on tumor cells has pivotal roles in proliferation, metastasis, and tumor cell "dormancy." Dormancy is associated with cytostatic drug resistance and is probably a property of tumor stem cells and minimal residual disease. Thus, hampering the SDF-1α/CXCR4 cross talk by a CXCR4 antagonist like Plerixafor (AMD3100) should overcome tumor cell dormancy bymobilization of tumor cells from "sanctuary" niches...
April 2013: Translational Oncology
https://www.readbyqxmd.com/read/22843210/tumor-therapy-with-a-urokinase-plasminogen-activator-activated-anthrax-lethal-toxin-alone-and-in-combination-with-paclitaxel
#6
Alexander N Wein, Shihui Liu, Yi Zhang, Andrew T McKenzie, Stephen H Leppla
PA-U2, an engineered anthrax protective antigen that is activated by urokinase was combined with wildtype lethal factor in the treatment of Colo205 colon adenocarcinoma in vitro and B16-BL6 mouse melanoma in vitro and in vivo. This therapy was also tested in combination with the small molecule paclitaxel, based on prior reports suggesting synergy between ERK1/2 inhibition and chemotherapeutics. Colo205 was sensitive to PA-U2/LF while B16-BL6 was not. For the combination treatment of B16-BL6, paclitaxel showed a dose response in vitro, but cells remained resistant to PA-U2/LF even in the presence of paclitaxel...
February 2013: Investigational New Drugs
https://www.readbyqxmd.com/read/22788954/fibroblast-secreted-hepatocyte-growth-factor-mediates-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitor-resistance-in-triple-negative-breast-cancers-through-paracrine-activation-of-met
#7
Kelly L Mueller, Julie M Madden, Gina L Zoratti, Charlotte Kuperwasser, Karin List, Julie L Boerner
INTRODUCTION: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have shown clinical efficacy in lung, colon, and pancreatic cancers. In lung cancer, resistance to EGFR TKIs correlates with amplification of the hepatocyte growth factor (HGF) receptor tyrosine kinase Met. Breast cancers do not respond to EGFR TKIs, even though EGFR is overexpressed. This intrinsic resistance to EGFR TKIs in breast cancer does not correlate with Met amplification. In several tissue monoculture models of human breast cancer, Met, although expressed, is not phosphorylated, suggesting a requirement for a paracrine-produced ligand...
2012: Breast Cancer Research: BCR
https://www.readbyqxmd.com/read/20354000/upregulation-of-dna-methyltransferase-mediated-gene-silencing-anchorage-independent-growth-and-migration-of-colon-cancer-cells-by-interleukin-6
#8
Eilis Foran, Megan M Garrity-Park, Coralie Mureau, John Newell, Thomas C Smyrk, Paul J Limburg, Laurence J Egan
Inflammatory bowel disease is characterized by chronic inflammation which predisposes to colorectal cancer. The mechanisms by which inflammation promotes tumorigenesis are not fully known. We aimed to investigate the links between colonic inflammation and tumorigenesis via epigenetic gene silencing. Colon cancer specimens were assessed for the expression of DNA methyltransferase-1 (DNMT-1) using immunohistochemistry. Colorectal carcinoma cell lines were assessed for DNMT1 expression, methylcytosine content, promoter methylation, gene expression, and tumorigenesis in response to interleukin (IL)-6...
April 2010: Molecular Cancer Research: MCR
https://www.readbyqxmd.com/read/20309938/intratumoral-injection-of-interferon-%C3%AE-and-systemic-delivery-of-agonist-anti-cd137-monoclonal-antibodies-synergize-for-immunotherapy
#9
Juan Dubrot, Asis Palazón, Carlos Alfaro, Arantza Azpilikueta, María Carmen Ochoa, Ana Rouzaut, Iván Martinez-Forero, Alvaro Teijeira, Pedro Berraondo, Agnes Le Bon, Sandra Hervás-Stubbs, Ignacio Melero
CD137 artificial costimulation results in complete tumor rejection in several mouse models. Type I interferons (IFN) exert antitumor effects through an array of molecular functions on malignant cells, tumor stroma and immune system cells. The fact that agonist anti-CD137 mAb induce tumor regressions in mice deficient in the unique receptor for Type I IFNs (IFNAR(-/-) ) indicated potential for treatment combinations. Indeed, combination of intratumor injections of mouse IFN-α and intraperitoneal injections of anti-CD137 mAb synergized as seen on subcutaneous lesions derived from the MC38 colon carcinoma, which is resistant to each treatment if given separately...
January 1, 2011: International Journal of Cancer. Journal International du Cancer
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"